{"cik":1750019,"taxonomy":"us-gaap","tag":"LesseeOperatingLeaseLiabilityPaymentsDue","label":"Lessee, Operating Lease, Liability, to be Paid","description":"Amount of lessee's undiscounted obligation for lease payment for operating lease.","entityName":"TCR2 Therapeutics Inc.","units":{"USD":[{"end":"2021-06-30","val":70844000,"accn":"0000950170-21-000860","fy":2021,"fp":"Q2","form":"10-Q","filed":"2021-08-05","frame":"CY2021Q2I"},{"end":"2021-09-30","val":69092000,"accn":"0000950170-21-003908","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-10","frame":"CY2021Q3I"},{"end":"2021-12-31","val":67134000,"accn":"0000950170-22-004299","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-22","frame":"CY2021Q4I"},{"end":"2022-03-31","val":97567000,"accn":"0000950170-22-009463","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-12","frame":"CY2022Q1I"},{"end":"2022-06-30","val":105408000,"accn":"0000950170-22-015242","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-08","frame":"CY2022Q2I"},{"end":"2022-09-30","val":97757000,"accn":"0000950170-22-022900","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-08","frame":"CY2022Q3I"},{"end":"2022-12-31","val":27451000,"accn":"0000950170-23-009312","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-23","frame":"CY2022Q4I"},{"end":"2023-03-31","val":6658000,"accn":"0000950170-23-020832","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-11","frame":"CY2023Q1I"}]}}